◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Gerresheimer AG (GXI) Financial History

Name: Gerresheimer AG (GXI) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Instruments & Supplies · DATA UPDATED 2026-08-16

Gerresheimer AG (GXI) operates in the Medical Instruments & Supplies industry and is headquartered in Düsseldorf, Germany with about 13,528 employees. Its market capitalization is roughly €938 million. In the fiscal year ended 2025-11-30, GXI reported €2.3B in revenue and (€320M) in net income.

Gerresheimer AG, together with its subsidiaries, provides drug containment solutions in Germany and internationally. The company operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies.

Interactive charts & full statements →

GXI Revenue & Earnings History — Annual Income Statement

Income statement	2025-11-30	2024-11-30	2023-11-30	2022-11-30	2021-11-30
Total Revenue	€2.3B	€2.0B	€2.0B	€1.8B	—
Gross Profit	€425M	€568M	€597M	€547M	—
Operating Income (EBIT)	(€71M)	€192M	€230M	€194M	—
Net Income	(€320M)	€82M	€116M	€96M	—

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

GXI Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2025-11-30	2025-05-31	2025-02-28	2024-11-30
Total Revenue	€640M	€601M	€520M	€569M
Gross Profit	€2M	€158M	€127M	€182M
Operating Income (EBIT)	(€144M)	€51M	€15M	€98M
Net Income	(€307M)	€17M	(€18M)	€37M

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

GXI Free Cash Flow History

GXI Balance Sheet History

Balance sheet	2025-11-30	2024-11-30	2023-11-30	2022-11-30	2021-11-30
Total Assets	€4.5B	€3.8B	€3.4B	€3.4B	—
Total Liabilities	€3.4B	€2.3B	€2.0B	€2.1B	—

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive GXI viewer.

Other Companies in Medical Instruments & Supplies

AZTA · Azenta, Inc. — $1 billion
SKAN · SKAN Group AG — $1 billion
1358 · PW Medtech Group Limited — $1 billion
STAA · STAAR Surgical Company — $1 billion
AVR · Anteris Technologies Global Corp. — $867 million
ANGO · AngioDynamics, Inc. — $649 million
NNNN · Anbio Biotechnology — $384 million
VBSN · IVF Hartmann Holding AG — $318 million

← GXAI All “G” companies GXO →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.